Studies have demonstrated that IgM and/or IgG antibodies against WT1 were detectable at a higher level in sera in patients with leukemia and myelodysplastic syndrome (MDS) compared with healthy individuals 33,36. The gene discussed is WT1; the disease is myelodysplastic syndrome.